NARNI, Franco
 Distribuzione geografica
Continente #
NA - Nord America 17.365
EU - Europa 7.620
AS - Asia 7.010
SA - Sud America 1.036
Continente sconosciuto - Info sul continente non disponibili 299
AF - Africa 173
OC - Oceania 17
Totale 33.520
Nazione #
US - Stati Uniti d'America 17.091
GB - Regno Unito 2.738
SG - Singapore 1.950
CN - Cina 1.898
IT - Italia 1.198
HK - Hong Kong 900
SE - Svezia 898
VN - Vietnam 810
BR - Brasile 751
DE - Germania 651
FI - Finlandia 463
UA - Ucraina 379
FR - Francia 344
RU - Federazione Russa 339
BD - Bangladesh 309
TR - Turchia 308
IN - India 175
KR - Corea 155
BG - Bulgaria 136
CA - Canada 136
AR - Argentina 96
ID - Indonesia 74
ES - Italia 69
JP - Giappone 66
MX - Messico 65
IQ - Iraq 62
NL - Olanda 51
EC - Ecuador 49
PL - Polonia 49
IE - Irlanda 48
BE - Belgio 44
ZA - Sudafrica 41
AE - Emirati Arabi Uniti 40
CZ - Repubblica Ceca 35
VE - Venezuela 34
PK - Pakistan 33
CO - Colombia 31
LT - Lituania 30
MY - Malesia 30
AT - Austria 27
CL - Cile 27
MA - Marocco 23
UZ - Uzbekistan 23
KE - Kenya 22
PH - Filippine 20
SA - Arabia Saudita 20
CH - Svizzera 19
EG - Egitto 19
TN - Tunisia 18
JM - Giamaica 17
RO - Romania 17
IR - Iran 16
AU - Australia 15
AZ - Azerbaigian 15
PY - Paraguay 15
BZ - Belize 12
DZ - Algeria 12
EU - Europa 12
IL - Israele 12
UY - Uruguay 12
JO - Giordania 11
PT - Portogallo 11
NP - Nepal 10
PE - Perù 10
SK - Slovacchia (Repubblica Slovacca) 10
TW - Taiwan 10
AL - Albania 9
BO - Bolivia 9
CR - Costa Rica 8
DK - Danimarca 8
ET - Etiopia 8
RS - Serbia 8
BH - Bahrain 7
CY - Cipro 7
GR - Grecia 7
HN - Honduras 7
KG - Kirghizistan 7
PA - Panama 6
PS - Palestinian Territory 6
TH - Thailandia 6
BY - Bielorussia 5
GT - Guatemala 5
HU - Ungheria 5
KZ - Kazakistan 5
DO - Repubblica Dominicana 4
LB - Libano 4
MK - Macedonia 4
NI - Nicaragua 4
OM - Oman 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
AM - Armenia 3
AO - Angola 3
EE - Estonia 3
MD - Moldavia 3
NG - Nigeria 3
NO - Norvegia 3
SC - Seychelles 3
SI - Slovenia 3
CM - Camerun 2
Totale 33.188
Città #
Southend 2.098
Ashburn 1.657
Fairfield 1.582
Santa Clara 1.400
Singapore 1.187
Woodbridge 994
Hong Kong 885
Chandler 841
Houston 837
Ann Arbor 738
Jacksonville 715
Seattle 591
Dearborn 575
Hefei 564
Wilmington 557
San Jose 553
Nyköping 552
Cambridge 506
New York 420
London 332
Beijing 322
Helsinki 304
Los Angeles 287
Chicago 276
Ho Chi Minh City 256
Modena 253
Council Bluffs 246
Hanoi 195
The Dalles 168
San Diego 151
Seoul 149
Princeton 144
Izmir 134
Sofia 134
Munich 131
Eugene 128
Milan 124
Lauterbourg 111
Buffalo 104
Salt Lake City 88
Fremont 80
Dallas 76
Bremen 71
Moscow 69
Shanghai 68
Columbus 67
São Paulo 64
Boardman 55
Des Moines 49
Frankfurt am Main 48
Orem 47
Dublin 46
Jakarta 46
Tokyo 46
Bologna 45
Rome 45
Tampa 42
Brussels 41
Phoenix 41
Elk Grove Village 40
Redwood City 39
Haiphong 38
Turku 38
Toronto 37
Warsaw 36
Da Nang 32
Montreal 32
Atlanta 31
Chennai 30
Brooklyn 29
San Francisco 29
Washington 29
Denver 26
Las Vegas 26
Rio de Janeiro 25
Dong Ket 24
Miami 24
Miano 24
Guangzhou 23
Lancaster 23
Quito 23
North Bergen 22
Sterling 22
Mexico City 21
Nanjing 21
Brno 20
Tashkent 20
Baghdad 19
Johannesburg 19
Nairobi 19
Stockholm 19
Biên Hòa 18
Kunming 18
Naples 18
Norwalk 18
Kilburn 17
Mountain View 17
Poplar 17
Albuquerque 16
Amsterdam 16
Totale 23.350
Nome #
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 605
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group 437
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 433
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 423
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 408
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 385
"Biologia molecolare delle leucemie e dei linfomi: Biologia molecolare della cellula, citogenetica e genetica molecolare 384
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 374
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 371
Mucorales-specific T cells in patients with hematologic malignancies 367
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 367
Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation 363
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 359
Acute appendicitis in adult neutropenic patients with hematologic malignancies 357
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 355
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 349
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study 348
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 345
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 344
[The treatment of the cardiac patient in dentistry and oromaxillofacial surgery. I. The practical management of patients with arrhythmias]. Il trattamento del paziente cardiopatico in odontoiatria ed in chirurgia oro-maxillo-facciale. Nota 1: Management pratico nei pazienti portatori di turbe del ritmo. 334
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation 329
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 329
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 327
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: Long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect 326
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 326
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 325
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 323
Altered expression of G1 specific genes in human malignant myeloid cells. 322
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 321
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 321
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen 320
Antilymphocyte globulin for prevention of chronic graft-versus-host disease 318
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 314
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome 314
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 314
Reassociation kinetics of the DNA of human acute leukemia cells. 313
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 310
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 306
Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study 304
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 302
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study 301
Accumulation of giant heterogeneous RNA molecules in acute myeloid leukemia blast cells. 292
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 292
T cell receptor genes expression in B cell leukaemias. 290
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 288
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 285
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 284
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 284
Bcl-2 gene expression in hematopoietic cell differentiation. 283
[Treatment of the patient with a coagulation defect in oral and maxillofacial surgery. III. The management of patients in a hypocoagulative state because of a hemophilic-type primary pathology]. Il trattamento del paziente con difetto di coagulazione in chirurgia orale e maxillo-facciale. Nota III: Il management dei pazienti in stato ipocoagulativo a causa di una patologia primaria di tipo emofilico. 280
[Management of patients with coagulation defect in oral and maxillofacial surgery. I. Management of patients with drug-induced hypocoagulation]. Il trattamento del paziente con difetto di coagulazione in chirurgia orale e maxillo-facciale. Il management dei pazienti in stato ipocoagulativo farmacoindotto. 277
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 277
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 276
KAPPA-LIGHT CHAIN GENE REARRANGEMENT IN A T-CELL LYMPHOMA 273
Retrospective analysis of mantle cell lymphoma: experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 272
Leucemia linfatica cronica 269
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 266
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 265
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 263
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 263
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: Results from the EBMT NMAM2000 prospective trial 261
In vitrocleavage of 45S pre-ribosomal RNA and of giant heterogeneous RNA extracted from human leukemic cells. 259
Study of the levels of expression of two oncogenes, c-myc and c-myb, in acute and chronic leukemias of both lymphoid and myeloid lineage.. 258
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome 257
Human Herpes virus-6 in human lymphomas: identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction 257
Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in cases of acute lymphoblastic leukemia. 255
[Management of patients with coagulation disorder in oral and maxillofacial surgery. II. Management of patients with hypocoagulation caused by primary thrombocytopathy]. Il trattamento del paziente con difetto di coagulazione in chirurgia orale e maxillo-facciale. Nota II. Il management dei pazienti in stato ipocoagulativo a causa di una patologia primaria trombocitopatica. 254
[The treatment of the cardiac patient in dentistry and oromaxillofacial surgery. II. The practical management of patients with hemodynamic pathologies]. Il trattamento del paziente cardiopatico in odontoiatria ed in chirurgia oro-maxillo-facciale. Nota 2: Management pratico nei portatori di patologie emodinamiche. 250
A multicenter randomized trial of two different ProMACE-CytaBOM derived protocols in aggressive non-Hodgkin's Lymphomas (NHL). A preliminary report 249
Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment 248
Treatment of refractory chronic GVHD with Rituximab: a GITMO study 247
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 245
Establishment and characterization of a human IgA-kappa-secreting plasma cell line (MT3). 244
The primary product of DNA transcription in the blast cell of acute leukemia. Its characterization as an approach to the understanding of the origin of the blast crisis of chronic myeloid leukemia 243
HLA DR associated invariant chain is highly expressed in chronic lymphocytic leukemia. 239
Allogeneic transplantation for multiple myeloma 239
ATYPICAL PATTERN OF LIGHT CHAIN GENE REARRANGEMENT IN HAIRY-CELL LEUKEMIA 236
Philadelphia positive chronic myeloid leukemia with 22 breakpoint outside the "beakpoint cluster region" (bcr). 236
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study 236
Immunological assay of double-helical segments in RNA fractions of different molecular size extracted from acute myeloid leukemia blast cells. 232
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation 227
[Management of facial pain resulting from cancer in oral and maxillofacial surgery]. Il trattamento del dolore facciale di natura oncologica in chirurgia oro-maxillo-facciale. 224
Different frequency classes of sequences in heterogeneous nuclear RNA of normal promyelocytes and lymphoblasts and of leukemic blast cells of circulating blood and of the HL60 line. 224
Segni sintomi e sindromi: leucocitosi, linfocitosi e linfopenie, linfoadenomegalie, splenomegalie e ipersplenismo. 223
Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it! 223
Immunoglobulin and T cell receptor beta chain gene rearrangements as lineage markers in human leukemias: a study of 78 cases. HAEMATOLOGICA 72, 391 397, 1987 222
Pain and emozional distress in hematological patients throughout all phases of disease: results from a multidisciplinary research team in Modena University Hospital 222
Bortezomib-thalidomide-dexamethasone is superior to thalidomide- dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 219
Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and sézary syndrome: A European society for blood and marrow transplantation lymphoma working party extended analysis 218
Tandem autologous/reduced-intensity allogeneic stem cell transplantation versus autologous transplantation in myeloma – long term follow up. 215
Characteristics of macromolecular RNA metabolism in leukemic promyelocytes of the HL 60 line 214
Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: Results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial 211
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavourably presenting Hodgkin's disease. A report from the Italian Lymphoma Study Group 210
Immunological evidence for the presence of double-stranded RNA regions in intact nuclei of normal human lymphocytes 207
Occurrence of a novel t(11;19)(q13;q13.3) in complete remission of acute promyelocytic leukemia 205
Cytomegalovirus reactivation after hematopoietic stem cell transplant with CMV-IG prophylaxis: A monocentric retrospective analysis 204
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED FOLLICULAR LYMPHOMAS: LOW TOXICITY AND EXTENDED PROGRESSION FREE SURVIVAL. R1235 Barcelona, Spain. Bone Marrow Transplantation March 2004, Volume 33, Supplement 1 200
Molecular study of the Philadelphia translocation in chronic myelogenous leukemia in different stages of the disease. 200
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial 200
The effect of cytosine-arabinoside treatment on the overexpression of c-myc protooncogene in a case of prolymphocytic leukemia. 196
Totale 28.861
Categoria #
all - tutte 126.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.476 0 320 253 171 56 117 140 153 262 175 534 295
2022/20232.541 346 319 212 243 338 325 65 216 279 25 97 76
2023/20241.773 53 81 102 135 324 302 188 242 27 31 94 194
2024/20254.885 161 53 108 315 950 718 453 247 498 188 468 726
2025/20269.875 673 412 842 1.130 1.571 684 1.159 496 954 856 677 421
2026/2027365 270 95 0 0 0 0 0 0 0 0 0 0
Totale 33.520